Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Apply
Cabozantinib & Lutetium-177
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step